Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects

Completed · Phase 3

Conditions studied: Pneumococcal Infections

In brief

To evaluate the safety of 13-valent pneumococcal conjugate vaccine (13vPnC) in elderly subjects who were vaccinated with one or more doses of 23-valent pneumococcal polysaccharide vaccine (23vPS) at least 3 years before study enrollment.

Key facts

Study ID

NCT00500266

Run by

Pfizer

People needed

1053

Starts

2008-05-01

Expected to finish

2009-05-01

Last updated by the study team

2011-09-16

Who can join

Age: 68 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Study site — Glendale, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Rolling Hills Estates, California, United States
• Study site — Apopka, Florida, United States
• Study site — Boynton Beach, Florida, United States
• Study site — Chiefland, Florida, United States
• Study site — Gainesville, Florida, United States
• Study site — Largo, Florida, United States
• Study site — Melbourne, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Atlanta, Georgia, United States
• Study site — Arkansas City, Kansas, United States
• Study site — Newton, Kansas, United States
• Study site — Wichita, Kansas, United States
• Study site — Wichita, Kansas, United States
• Study site — Crescent Springs, Kentucky, United States
• Study site — New Orleans, Louisiana, United States
• Study site — Nitchitoches, Louisiana, United States
• Study site — Camillus, New York, United States
• Study site — Rochester, New York, United States
• Study site — Raleigh, North Carolina, United States
• Study site — Akron, Ohio, United States
• Study site — Chandler, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.